From April 1, 2023 to May 10, 2023, the company has repurchased 600 shares, representing 0.000064% for CNY 0.009588 million. With this, the company has completed the repurchase of 2,560,300 shares, representing 0.27% for CNY 30 million under the buyback announced on June 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.88 CNY | -0.54% | +1.82% | +5.92% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.92% | 1.68B | |
+32.36% | 694B | |
+29.85% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.66% | 239B | |
-3.39% | 209B | |
+10.25% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 603567 Stock
- News Heilongjiang ZBD Pharmaceutical Co., Ltd.
- Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.